Chan KA - Search Results

1

The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative.

Newton KM, Buist DS, Miglioretti DL, Beverly K, Hartsfield CL, Chan KA, Andrade SE, Wei F, Connelly MT, Kessler L. Newton KM, et al. Among authors: chan ka. J Gen Intern Med. 2005 Apr;20(4):350-6. doi: 10.1111/j.1525-1497.2005.04059.x. J Gen Intern Med. 2005. PMID: 15857493 Free PMC article.

2

Hormone therapy prescribing patterns in the United States.

Buist DS, Newton KM, Miglioretti DL, Beverly K, Connelly MT, Andrade S, Hartsfield CL, Wei F, Chan KA, Kessler L. Buist DS, et al. Among authors: chan ka. Obstet Gynecol. 2004 Nov;104(5 Pt 1):1042-50. doi: 10.1097/01.AOG.0000143826.38439.af. Obstet Gynecol. 2004. PMID: 15516400

3

Hormone therapy initiation after the Women's Health Initiative.

Newton KM, Buist DS, Yu O, Hartsfield CL, Andrade SE, Wei F, Connelly MT, Chan KA. Newton KM, et al. Among authors: chan ka. Menopause. 2008 May-Jun;15(3):487-93. doi: 10.1097/gme.0b013e318154b9a5. Menopause. 2008. PMID: 18188140

4

Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.

Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH. Andrade SE, et al. Among authors: chan ka. Arch Intern Med. 2003 Sep 22;163(17):2052-7. doi: 10.1001/archinte.163.17.2052. Arch Intern Med. 2003. PMID: 14504118

5

Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income.

Wei F, Miglioretti DL, Connelly MT, Andrade SE, Newton KM, Hartsfield CL, Chan KA, Buist DS. Wei F, et al. Among authors: chan ka. J Natl Cancer Inst Monogr. 2005;(35):106-12. doi: 10.1093/jncimonographs/lgi047. J Natl Cancer Inst Monogr. 2005. PMID: 16287895

6

Laboratory monitoring of drugs at initiation of therapy in ambulatory care.

Raebel MA, Lyons EE, Andrade SE, Chan KA, Chester EA, Davis RL, Ellis JL, Feldstein A, Gunter MJ, Lafata JE, Long CL, Magid DJ, Selby JV, Simon SR, Platt R. Raebel MA, et al. Among authors: chan ka. J Gen Intern Med. 2005 Dec;20(12):1120-6. doi: 10.1111/j.1525-1497.2005.0257.x. J Gen Intern Med. 2005. PMID: 16423101 Free PMC article.

7

Gastric and duodenal safety of daily alendronate.

Donahue JG, Chan KA, Andrade SE, Beck A, Boles M, Buist DS, Carey VJ, Chandler JM, Chase GA, Ettinger B, Fishman P, Goodman M, Guess HA, Gurwitz JH, LaCroix AZ, Levin TR, Platt R. Donahue JG, et al. Among authors: chan ka. Arch Intern Med. 2002 Apr 22;162(8):936-42. doi: 10.1001/archinte.162.8.936. Arch Intern Med. 2002. PMID: 11966346

8

Methods for evaluation of medication adherence and persistence using automated databases.

Andrade SE, Kahler KH, Frech F, Chan KA. Andrade SE, et al. Among authors: chan ka. Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):565-74; discussion 575-7. doi: 10.1002/pds.1230. Pharmacoepidemiol Drug Saf. 2006. PMID: 16514590 Review.

9

Comparison of drug adherence rates among patients with seven different medical conditions.

Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Briesacher BA, et al. Among authors: chan ka. Pharmacotherapy. 2008 Apr;28(4):437-43. doi: 10.1592/phco.28.4.437. Pharmacotherapy. 2008. PMID: 18363527 Free PMC article.

10

Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.

Herrinton LJ, Liu L, Lafata JE, Allison JE, Andrade SE, Korner EJ, Chan KA, Platt R, Hiatt D, O'Connor S. Herrinton LJ, et al. Among authors: chan ka. Inflamm Bowel Dis. 2007 Apr;13(4):451-61. doi: 10.1002/ibd.20021. Inflamm Bowel Dis. 2007. PMID: 17219403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

434 results

Search Page